KBC Group NV Cuts Holdings in Itron, Inc. $ITRI

KBC Group NV cut its holdings in Itron, Inc. (NASDAQ:ITRI) by 0.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,107 shares of the scientific and technical instruments company’s stock after selling 581 shares during the quarter. KBC Group NV owned 0.18% of Itron worth $10,544,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Bessemer Group Inc. lifted its holdings in Itron by 125.7% in the second quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 142 shares during the period. REAP Financial Group LLC lifted its stake in shares of Itron by 168.4% in the second quarter. REAP Financial Group LLC now owns 424 shares of the scientific and technical instruments company’s stock valued at $56,000 after purchasing an additional 266 shares during the period. Allworth Financial LP lifted its stake in shares of Itron by 63.8% in the second quarter. Allworth Financial LP now owns 696 shares of the scientific and technical instruments company’s stock valued at $92,000 after purchasing an additional 271 shares during the period. Quarry LP boosted its holdings in Itron by 155.6% during the first quarter. Quarry LP now owns 910 shares of the scientific and technical instruments company’s stock worth $95,000 after buying an additional 554 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Itron by 20.0% during the second quarter. Nisa Investment Advisors LLC now owns 1,008 shares of the scientific and technical instruments company’s stock worth $133,000 after buying an additional 168 shares during the period. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Buying and Selling

In other Itron news, SVP John F. Marcolini sold 565 shares of the firm’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the sale, the senior vice president directly owned 14,396 shares of the company’s stock, valued at $1,803,962.76. This trade represents a 3.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Justin K. Patrick sold 388 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $48,620.28. Following the completion of the transaction, the senior vice president directly owned 20,761 shares of the company’s stock, valued at approximately $2,601,560.91. This represents a 1.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 3,037 shares of company stock worth $380,566 in the last 90 days. 1.51% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ITRI has been the subject of a number of research reports. Roth Capital lifted their price target on shares of Itron from $130.00 to $150.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. Zacks Research cut Itron from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Weiss Ratings reiterated a “buy (b-)” rating on shares of Itron in a research report on Thursday. Oppenheimer set a $145.00 price target on Itron and gave the company an “outperform” rating in a research report on Friday, October 31st. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $118.00 price target (down previously from $137.00) on shares of Itron in a research note on Friday, October 31st. Nine equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Itron currently has an average rating of “Moderate Buy” and a consensus target price of $139.00.

Itron Price Performance

Shares of NASDAQ:ITRI opened at $98.46 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The business’s fifty day moving average price is $120.95 and its two-hundred day moving average price is $122.88. The stock has a market cap of $4.51 billion, a PE ratio of 16.83, a price-to-earnings-growth ratio of 0.76 and a beta of 1.52. Itron, Inc. has a one year low of $90.11 and a one year high of $142.00.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.06. The business had revenue of $581.63 million for the quarter, compared to the consensus estimate of $578.49 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business’s revenue was down 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. On average, analysts forecast that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.